Sexual Dysfunction

Should genitourinary medicine clinic attendees with sexual dysfunctions have routine assessment of testosterone levels?
pp. 1-5(5)
Authors: GOLDMEIER, D.; KEANE, F. E. A.; HARRIS, J. R. W.; GREEN, J.

The psychosexual aspects of genital herpes
pp. 7-12(6)
Authors: WILKINSON, D.; BARTON, S.

Cultural beliefs and the treatment of sexual dysfunction: an overview
pp. 13-17(5)
Authors: PETRAK, J.; KEANE, F.

Efficacy and safety of intracavernosal alprostadil alfadex in the treatment of erectile dysfunction
pp. 19-24(6)
Authors: GINGELL, C.; BURNS-COX, N.; EVANS, C.; MORGAN, R.; WILLIAMS, G.; FOSTER, M.; BAXTER, T.

Sexual dysfunction as presented in a routine genitourinary medicine clinic compared with that within a specialist psychosexual clinic
pp. 25-29(5)
Author: CROWLEY, T.

Erectile-dysfunction clinic non-attendees
pp. 31-33(3)
Authors: LARKIN, C. J.; DINSMORE, W. W.

Intracavernous injection test in the evaluation of patients with erectile dysfunction: a blind, cross-over placebo-controlled study between three different vasoactive agents in 30 impotent patients
pp. 35-38(4)
Authors: KUNELIUS, P.; LUKKARINEN, O.

The effect of alkalized papaverine on papaverine-induced pain
pp. 39-41(3)
Authors: ÇAL, Ç.; KESKIN, D.; AVCIERI, V.; DELIBAŞ, M.; ÖZYURT, C.; CÜREKLIBATIR, I.

Diagnosis and treatment of erectile dysfunction in retrospect
pp. 43-47(5)
Authors: SLOB, A. K.; LOTTMAN, P. E. M.; HOP, W. C. J.; INCROCCI, L.; BOSCH, J. J. VAN DER WERFF TEN

Priapism induced by intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate
pp. 49-51(3)
Authors: CHIN, M. T. M.; LEE, S. M.; DINSMORE, W. W.

Isolated lymphoedema of the external genitalia
pp. 53-56(4)
Authors: ROOIJ, J. VAN DE WETERING DE; DRIEL, M. F. VAN; ROBINSON, P. H.; MENSINK, H. J. A.

Relapsing erysipelas mimicking priapism 12 h after coitus
pp. 57-58(2)
Authors: BÖHMER, U.; KORTING, H. C.